about
Molecular targets of aspirin and cancer prevention.The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potentialAspirin induces apoptosis through the inhibition of proteasome functionPrevention of skin carcinogenesis by the β-blocker carvedilolHydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signalingRepurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposisAspirin delimits platelet life span by proteasomal inhibitionOverexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and nonselective COX inhibitorsAldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells.Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: Involvement of iNOS and COX-2.Nanoparticulate delivery of novel drug combination regimens for the chemoprevention of colon cancerFrom COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation.Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cellsChemoprevention by nonsteroidal anti-inflammatory drugs eliminates oncogenic intestinal stem cells via SMAC-dependent apoptosis.Anticancer activity and chemoprevention of xenobiotic organosulfurs in preclinical model systemsAntiproliferative effect of sulindac in colonic neoplasia prevention: role of COOH-terminal Src kinase.Aspirin for the primary prevention of skin cancer: A meta-analysisTargeting aldose reductase for the treatment of cancerChemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention.Effect of Rumex Abyssinicus on preneoplastic lesions in dimethylhydrazine induced colon carcinogenesis in ratsTolfenamic acid suppresses cytochrome P450 2E1 expression in mouse liverCyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors.Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer PreventionIbuprofen inhibits colitis-induced overexpression of tumor-related Rac1bMouse models of DNA mismatch repair in cancer research.Novel Therapeutics: NSAIDs, Derivatives, and Phosphodiesterases.Chemoprevention of colorectal cancer: two steps forward, one step back?Structure, biochemistry and biology of hepoxilins: an update.A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.Suppression of familial adenomatous polyposis by CP-31398, a TP53 modulator, in APCmin/+ mice11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal TumorigenesisColorectal carcinogenesis: Review of human and experimental animal studies.Role of apoptosis in colon cancer biology, therapy, and preventionModulation of carcinogen metabolism by nitric oxide-aspirin 2 is associated with suppression of DNA damage and DNA adduct formation.Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers.The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer.Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10Aspirin and low-dose nitric oxide-donating aspirin increase life span in a Lynch syndrome mouse model.
P2860
Q27687847-7DE3286C-CAF9-4135-9566-6920919F0D1BQ28195754-2E639C34-A661-491D-974C-75CEEFF33FBDQ28199915-1E5B8EFC-3B12-48B0-9798-CBBB8E016A58Q28385654-2DE07E57-5F7A-45C5-8897-46CC5B142CE3Q28387183-2F0604FC-AA0A-4756-B081-091EFD8B8472Q28540528-E4A5484A-4458-4655-81A0-DB5BF68190F4Q28542013-9718A0E5-1045-4992-9516-A3F4952AF533Q33584254-4C383628-981F-441F-A35F-832C37717139Q33600379-4AE1D3BA-5CC3-4A33-ABA3-5180021BFD7EQ33817129-89C58874-B683-4A41-AA3D-71D33CBE6135Q33833049-8C28C013-E257-4891-B9D6-649C5246CC52Q33984297-B629165D-859D-4B6D-B21D-7D5D70851DB4Q34084150-A7384379-7AF4-45D1-BB77-1523B0B4AD43Q34159639-0C52804C-20ED-41B7-81FE-BC9D62FD41CBQ34359198-D6AB221D-51BC-4E98-A574-DF867D4AB6ABQ34463928-63DE6456-DE66-4F18-99B4-92DE149C9CF1Q34594558-A9201F70-E857-4CDF-8E41-70620F05DC87Q35041988-2489B5A4-502B-44DD-8231-A95BCF9F5A28Q35125587-A5B6B8FB-6AF8-4C86-918D-3EE7F177651DQ35597223-53A00EA0-9E08-46F9-AACE-B6FD4825ED93Q35809179-7D6849B2-AB3F-4EE8-8489-2572C38FCB5BQ36217454-68062EC2-6FE1-4B71-B6F6-6A0E0CE41A44Q36498885-C353DCA0-A218-447D-BE64-5C4280B8969FQ36503568-332E66F9-8DFE-460D-8DD7-A3B4C4CA0E0BQ36567588-0AD666F0-399C-4826-BAF2-A910ABBA972CQ36583537-8800798E-DAD1-45D4-B92B-D104FBCC83DAQ36637814-7B780E66-2FD1-4022-833B-12F15B1968F1Q36677468-728192F7-97C2-40B9-B87F-97AEAB81A3ECQ36869340-173DC006-C168-488C-868C-B9502B3EBB64Q36922601-5D53BA66-5AC9-4073-BEBD-BC9DB16DE4E8Q37002735-41B66DAE-FFA0-496E-8FCB-021AA2EC9FD7Q37078077-7026DFF6-B9D8-4ACB-9465-F8140FFCAACFQ37183760-8988B87C-3291-44B3-860F-2E32B1941739Q37331465-93B7944B-EC79-4644-88E2-7A7C97AC5A9DQ37372211-50E4F180-3863-4D3F-83D7-B891A92E3E0CQ37415607-CF31129F-6C24-4B07-AFF0-E40CDC26FC2AQ37457596-01FC3CBC-BA90-458B-BD62-F7CD583661CBQ37473855-CFD2C684-75D6-40BA-B03B-4BA2BCEDB58CQ37624504-7C1F0A69-C0A9-4667-A293-2895FAE9C6B7Q37709953-DA079041-C1F9-435B-AA33-68F1E0494D30
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
NSAIDs and chemoprevention
@ast
NSAIDs and chemoprevention
@en
NSAIDs and chemoprevention
@nl
type
label
NSAIDs and chemoprevention
@ast
NSAIDs and chemoprevention
@en
NSAIDs and chemoprevention
@nl
prefLabel
NSAIDs and chemoprevention
@ast
NSAIDs and chemoprevention
@en
NSAIDs and chemoprevention
@nl
P3181
P356
P1476
NSAIDs and chemoprevention
@en
P2093
Bandaru S Reddy
Chinthalapally V Rao
P3181
P356
10.2174/1568009043481632
P407
P577
2004-02-01T00:00:00Z